| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 96 |
| 1 | LAMIVUDINE | 77 |
| 2 | LAMIVUDINE ORAL | 76 |
| 3 | ZIDOVUDINE | 75 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE | 67 |
| 5 | GABAPENTIN | 66 |
| 6 | ADALIMUMAB | 61 |
| 7 | LIDOCAINE HYDROCHLORIDE | 59 |
| 8 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 58 |
| 9 | INTERFERON BETA-1A | 56 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | 1 | 0.0667 |
| 1 | AESCULUS HIPPOCASTANUM WHOLE | 3 | 0.0400 |
| 2 | AGRIMONIA EUPATORIA | 3 | 0.0395 |
| 3 | CENTAURIUM ERYTHRAEA | 3 | 0.0390 |
| 4 | BISACODYL SUPPOSITORY | 1 | 0.0303 |
| 5 | FRANKINCENSE | 1 | 0.0164 |
| 6 | NELFINAVIR MESYLATE | 24 | 0.0115 |
| 7 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 8 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 9 | ETRAVIRINE | 33 | 0.0074 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 2 | 0.0039 |
| 1 | Endoglycosidase [EPC] | 6 | 0.0032 |
| 2 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 34 | 0.0025 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 51 | 0.0021 |
| 4 | Protease Inhibitor [EPC] | 70 | 0.0016 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 76 | 0.0015 |
| 6 | Neonatal Fc Receptor Blocker [EPC] | 6 | 0.0014 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 26 | 0.0013 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 70 | 0.0012 |
| 9 | Plasma Volume Expander [EPC] | 3 | 0.0010 |